Venmax Drugs Board Approves AGM, Director Appointments

Venmax Drugs and Pharmaceuticals Ltd held a Board of Directors meeting on August 31, 2026. The board approved the Notice & Directors Report for FY 2025-2026, the Secretarial Audit Report, and set the 37th Annual General Meeting for September 26, 2026. Key decisions included approving e-voting dates from September 23-25, 2026, with a cut-off date of September 18, 2026. The Register of Members will be closed from September 18-26, 2026. M/s Kashinath Sahu & Co. was appointed as the scrutinizer. The board also approved the change in designation of Mr. Venkata Rao Sadhanala to Managing Director and the regularization of Mrs. Padmaja Kalyani Sadhanala and Mr. Revoor Ramachandra as directors, subject to shareholder approval.